Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Computer simulation of final height after growth-promoting therapy

J Karlberg1

  • 1Department of Paediatrics, Queen Mary Hospital, University of Hong Kong, Hong Kong.

Acta Paediatrica (Oslo, Norway : 1992). Supplement
|October 1, 1996
PubMed
Summary

Final height prediction significantly impacts growth therapy response estimation. Mean residual final height is a robust measure, but treatment residual final height depends more on prediction intervals than treatment efficacy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Longitudinal study on the age at childhood onset in children from Shanghai and its effects on child growth].

Zhonghua er ke za zhi = Chinese journal of pediatrics·2005
Same author

Birthweight and psychological distress in adult twins: a longitudinal study.

Acta paediatrica (Oslo, Norway : 1992)·2004
Same author

Maternal smoking: an increasing unique risk factor for sudden infant death syndrome in Sweden.

Acta paediatrica (Oslo, Norway : 1992)·2004
Same author

Refining the Apgar score cut-off point for newborns at risk.

Acta paediatrica (Oslo, Norway : 1992)·2004
Same author

Do men have a higher case fatality rate of severe acute respiratory syndrome than women do?

American journal of epidemiology·2004
Same author

Do sensational media reports about severe acute respiratory syndrome affect the mindset of healthcare workers?

Acta paediatrica (Oslo, Norway : 1992)·2003

Area of Science:

  • Pediatrics
  • Endocrinology
  • Growth Medicine

Background:

  • Accurate estimation of growth response to therapy is crucial for pediatric endocrine disorders.
  • Final height prediction methods are essential but can introduce variability in growth response assessments.
  • Understanding the influence of prediction accuracy on treatment outcomes is vital for clinical practice.

Purpose of the Study:

  • To investigate the impact of final height prediction on the estimation of growth response to therapy.
  • To evaluate the robustness of different outcome measures in growth-promoting studies.
  • To determine the correlation between predicted final height, actual final height, and treatment-induced growth gain.

Main Methods:

  • Analysis of simulated treatment data for 28 prepubertally short boys.

Related Experiment Videos

  • Calculation of mean residual final height and treatment residual final height.
  • Correlation analysis between predicted final height, actual final height, and treatment gain.

    • Main Results:

    • Mean residual final height demonstrated robustness as an outcome measure in growth-promoting studies.
    • Treatment residual final height showed a moderate correlation (r² = 0.27) with actual growth gain.
    • Treatment residual final height was highly correlated (r² = 0.75) with residual final height, indicating dependence on prediction intervals.

    Conclusions:

    • Mean residual final height is a reliable metric for assessing growth promotion.
    • Growth response estimations based on treatment residual final height may be more influenced by prediction accuracy than treatment effectiveness.
    • Clinical interpretation of growth therapy outcomes requires careful consideration of final height prediction intervals.